February 2026
The global pour point depressant market size was evaluated at USD 2.41 billion in 2025 and is predicted to hit around USD 3.78 billion by 2035, growing at a CAGR of 4.61%.
August 2025
The global crude oil pour point depressant market size was estimated at USD 1.25 billion in 2024 and is expected to hit around USD 3.11 billion by 2034, growing at a CAGR of 9.56%.
June 2026
The global veterinary point of care diagnostics market size is estimated to hit around USD 7.87 billion by 2035 from USD 2.96 billion in 2025, with a CAGR of 10.27%.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global point-of-care diagnostics market size is exhibited at USD 64.08 billion in 2025 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
June 2026
The global appointment scheduling software market size was evaluated at USD 554.11 million in 2025 and is predicted to hit around USD 2,206.84 million by 2035, growing at a CAGR of 14.82%.
May 2026
The global point-of-sale terminals market size is valued at USD 107.75 billion in 2025 and is expected to hit around USD 266.15 billion by 2035, with a CAGR of 9.46%.
April 2026
The point-of-sale software market size was estimated at USD 16.37 billion in 2025 and is projected to hit around USD 45.34 billion by 2035 with a CAGR of 10.72%.
April 2026
The global immune checkpoint inhibitors market size is predicted to hit around USD 258.91 billion by 2035 from USD 58.53 billion in 2025 with a CAGR of 16.03%.
March 2026
The point of care testing market size is expected to increase from USD 44.48 billion in 2025 and is projected to hit around USD 125.33 billion by 2034 with a CAGR of 12.20%.
February 2026
The global point-of-care molecular diagnostics market size was valued at USD 8.95 billion in 2025 and is expected to hit around USD 13.06 billion by 2035, at a CAGR of 3.85%.
February 2026
The point-of-use water treatment systems market size was valued at USD 37.68 billion in 2025 and is expected to hit around USD 89.83 billion by 2035, with a CAGR of 9.08%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
December 2025
The point-of-care medical imaging market size is exhibited at USD 1.39 billion in 2025 and is expected to hit around USD 2.16 billion by 2035 with a CAGR of 4.51%.
December 2025
The global point-of-care biosensors market size is calculated at USD 90.65 billion in 2025 and is projected to hit around USD 200.37 billion by 2035 with a CAGR of 8.25%.
November 2025
The global point-of-care glucose testing market size is expected to hit around USD 5.72 billion by 2035 from USD 3.80 billion in 2025 with a CAGR of 4.17%.
August 2025
The global handheld point of sale market size was evaluated at USD 30.12 billion in 2024 and is predicted to hit around USD 80.65 billion by 2034, growing at a CAGR of 10.35%.
July 2025
The restaurant point-of-sale terminal market size is expected to surge around USD 52.18 billion by 2034 from USD 24.10 billion in 2024, with a solid CAGR of 8.03%.
July 2025
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
July 2025
The global point-of-care ultrasound market size was estimated at USD 3.97 billion in 2024 and is predicted to surpass around USD 7.93 billion by 2034, with a CAGR of 7.20%.
July 2025
The global point of care lipid test market size was valued at USD 307.71 million in 2024 and is predicted to attain around USD 472.54 million by 2034 with a CAGR of 4.38%.
June 2025
The global antidepressant drugs market size was evaluated at USD 18.99 billion in 2024 and is projected to cross around USD 26.06 billion by 2034, with a CAGR of 3.22%.
January 2025
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
July 2025
The global syphilis immunoassay diagnostics market size is estimated to hit around USD 992.65 million by 2034 from USD 578.93 million in 2024, with a CAGR of 5.54%.